Clinical Research Directory
Browse clinical research sites, groups, and studies.
Combination of Conditioned Medium and Umbilical Cord-Mesenchymal Stem Cells Therapy for Acute Stroke Infarct
Sponsor: PT. Prodia Stem Cell Indonesia
Summary
The purpose of this study was to determine the effectiveness of a combination of intranasal conditioned medium (CM) with intraparenchymal umbilical cord mesenchymal stem cells (UC-MSCs) transplantation in acute stroke patients to induce neurogenesis.
Official title: Safety and Efficacy of Combined Conditioned Medium With Umbilical Cord Mesenchymal Stem Cells as A Novel Strategy for Acute Stroke Infarct
Key Details
Gender
All
Age Range
25 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
15
Start Date
2022-05-30
Completion Date
2026-03
Last Updated
2026-02-25
Healthy Volunteers
No
Conditions
Interventions
Conditioned Medium
Intranasal of 3 cc of conditioned medium each, for 3 days in a row
Umbilical Cord Mesenchymal Stem Cells
Intra-parenchymal transplantation of 20x10\^6 UC-MSCs
Neurologic and Neutrophic Drugs
Such as clopidogrel, piracetam, citicoline
Locations (2)
Gatot Soebroto Hospital
Jakarta Pusat, DKI Jakarta, Indonesia
PT Prodia StemCell Indonesia
Jakarta, Indonesia